TCT-290 Outcomes After Revascularization With a Polymer-Free Biolimus-Eluting BioFreedom Stent or a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Orsiro Stent in Patients With and Without Acute Coronary Syndromes: From the SORT OUT IX Trial

Christian Fallesen,Evald Christiansen,Bent Raungaard,Michael Maeng,Julia Ellert,Christian Terkelsen,Martin Kirk Christensen,Anders Junker,Steen Dalby Kristensen,Henrik Hansen,Svend Eggert Jensen,Johnny Kahlert,Jens Lassen,Lisette Okkels Jensen

doi:10.1016/j.jacc.2019.08.365

TCT-290 Outcomes After Revascularization With a Polymer-Free Biolimus-Eluting BioFreedom Stent or a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Orsiro Stent in Patients With and Without Acute Coronary Syndromes: From the SORT OUT IX Trial

Christian Fallesen, Evald Christiansen + Show 12 more

Open Access

https://doi.org/10.1016/j.jacc.2019.08.365

Copy DOI

Journal: Journal of the American College of Cardiology	Publication Date: Sep 23, 2019
License type: publisher-specific-oa

Affiliation: Aarhus University, Aarhus University Hospital, Odense University Hospital, Aalborg University Hospital

#SORT OUT #Sirolimus-eluting Stent + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

In the SORT OUT IX trial, the biolimus A9-coated BioFreedom stent, a stainless steel drug-coated stent devoid of polymer (BF-BES), did not show noninferiority to the biodegradable polymer ultrathin strut sirolimus-eluting Orsiro stent (O-SES). The aim of this substudy was to compare the clinical

Full Text